A REVIEW: ANTI-DIABETIC ACTIVITY OF HERBAL DRUGS
{ DOWNLOAD AS PDF }
Novo Nordisk, a world leader in insulin and diabetes care, has launched Saxenda (liraglutide 3 mg), the first glucagon-like peptide-1 (GLP-1) receptor agonist the United States. Saxenda is a drug used to treat obesity. Saxenda has approved in the US, EU and Canada.
Hello sir,
I am Bhavika Dalvi, studying advance post graduate diploma in clinical research and management. I have completed B.Pharmacy in 2014 and currently looking for a job.